CEO Andrew Hider was paid $29,805,182 in fiscal year 2025, the 99th percentile of its disclosed peer group (SEC filing 0001628280-26-020330 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$29,805,182 Andrew Hider total, FY2025 | 99th CEO pay percentile vs peers | 445:1 CEO-to-median pay ratio | 91.16% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
BAX's next annual pay disclosure, estimated March 21, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Andrew Hider | $499,315 | $1,000,000 | $23,133,518 | $3,185,053 | $820,125 | $0 | $1,167,171 | $29,805,182 |
| President and CEO | ||||||||
| Joel Grade | 827,825 | 0 | 5,809,671 | 1,049,372 | 459,000 | 0 | 63,700 | 8,209,568 |
| Former Executive Vice President and CFO | ||||||||
| José Almeida | 660,420 | 0 | 0 | 0 | 0 | 0 | 7,005,624 | 7,666,044 |
| Former Chair of the Board, President and CEO | ||||||||
| Heather Knight | 747,123 | 0 | 4,018,281 | 1,267,349 | 0 | 0 | 41,795 | 6,074,548 |
| Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies | ||||||||
| Reazur Rasul | 800,000 | 0 | 2,953,421 | 931,507 | 488,000 | 0 | 73,286 | 5,246,214 |
| Executive Vice President and Group President, Healthcare Systems & Technologies | ||||||||
| Alok Sonig | 779,747 | 0 | 3,375,371 | 1,064,578 | 0 | 0 | 19,577 | 5,239,273 |
| Former Executive Vice President and Group President, Pharmaceuticals | ||||||||
| Brent Shafer | 701,644 | 654,839 | 2,400,815 | 0 | 0 | 0 | 52,695 | 3,809,993 |
| Non-Executive Chair and Former Executive Chair and Interim CEO | ||||||||
| David Rosenbloom | 760,000 | 0 | 1,989,036 | 627,345 | 348,840 | 0 | 68,943 | 3,794,164 |
| Executive Vice President and General Counsel | ||||||||
| Cecilia Soriano | 668,247 | 75,000 | 1,300,147 | 253,472 | 291,732 | 0 | 66,243 | 2,654,841 |
| Group President, Infusion Therapies & Technologies and Pharmaceuticals | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Andrew Hider | $29,805,182 | — | — | — |
| Joel Grade | 8,209,568 | 6,507,548 | 4,876,222 | ↑ +1,702,020 |
| José Almeida | 7,666,044 | 18,071,015 | 13,786,671 | ↓ −10,404,971 |
| Heather Knight | 6,074,548 | 6,596,490 | 4,860,243 | ↓ −521,942 |
| Reazur Rasul | 5,246,214 | — | — | — |
| Alok Sonig | 5,239,273 | 5,345,806 | 3,866,033 | ↓ −106,533 |
| Brent Shafer | 3,809,993 | — | — | — |
| David Rosenbloom | 3,794,164 | — | — | — |
| Cecilia Soriano | 2,654,841 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read BAXTER INTERNATIONAL INC's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper BAX reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the BAXTER INTERNATIONAL INC Peer Teardown Report
$29,805,182 Andrew Hider total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of September 3, 2026 · Source: 0001628280-26-020330 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for BAX
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order BAX
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
Each company listed discloses BAX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named BAX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Get the BAXTER INTERNATIONAL INC Executive Compensation Report
$1,500
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Amy A. Wendell | Independent Director | $354,987 |
| Cathy R. Smith | Independent Director | $364,987 |
| David S. Wilkes | Independent Director | $366,848 |
| Jeffrey A. Craig | Independent Director | $359,987 |
| Nancy M. Schlichting | Independent Director | $393,565 |
| Patricia B. Morrison | Independent Director | $361,585 |
| Stephen H. Rusckowski | Independent Director | $354,987 |
| Stephen N. Oesterle | Independent Director | $374,487 |
| William A. Ampofo II | Independent Director | $337,436 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Jeffrey A. Craig | Director | 2026-05-05 | A | 12,836 | $0 | $0 | Common | Form 4 ↗ |
| Michael R. McDonnell | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| Brent Shafer | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| Patricia B. Morrison | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| David S. Wilkes | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| Amy A. Wendell | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| William A. Ampofo II | Director | 2026-05-05 | A | 12,836 | 0 | 0 | Common | Form 4 ↗ |
| Anita A. Zielinski | SVP, Interim CFO, CAO & Cntrlr | 2026-06-01 | A | 13,426 | 0 | 0 | Common | Form 4 ↗ |
| James Teaff | President, CCS | 2026-06-02 | D | 321 | 19 | 5,996 | Common | Form 4 ↗ |
| Steven P. Wallace | President, Adv. Surgery | 2026-06-02 | D | 153 | 19 | 2,858 | Common | Form 4 ↗ |
| James Teaff | President, CCS | 2026-09-01 | D | 750 | 25 | 19,110 | Common | Form 4 ↗ |
| Julie Foster | President, Front Line Care | 2026-09-02 | D | 2,098 | 26 | 53,919 | Common | Form 4 ↗ |
| Andrew Hider | Director | 2026-09-02 | D | 54,276 | 26 | 1,394,893 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Joel Grade | PSU | 2025-03-06 | 29,538 | 59,075 | — | 118,150 | $2,280,295 |
| Heather Knight | OPTION | 2025-03-06 | — | — | 118,934 | — | 1,267,349 |
| Heather Knight | PSU | 2025-03-06 | 35,674 | 71,347 | — | 142,694 | 2,753,994 |
| Brent Shafer | RSU | 2025-02-05 | — | — | 76,289 | — | 2,400,815 |
| Heather Knight | RSU | 2025-03-06 | — | — | 35,674 | — | 1,264,287 |
| Andrew Hider | RSU | 2025-09-02 | — | 5 | — | 236,237 | 5,709,848 |
| Andrew Hider | RSU | 2025-09-02 | 1 | 5 | — | 131,813 | 3,185,920 |
| Andrew Hider | OPTION | 2025-09-02 | — | — | 465,651 | — | 3,185,053 |
| Andrew Hider | PSU | 2025-09-02 | 131,814 | 263,626 | — | 527,252 | 6,938,636 |
| Andrew Hider | PSU | 2025-09-02 | 82,170 | 164,339 | — | 328,678 | 4,325,402 |
| Reazur Rasul | RSU | 2025-03-06 | — | — | 26,220 | — | 929,237 |
| Andrew Hider | PSU | 2025-09-02 | 56,492 | 112,983 | — | 225,966 | 2,973,712 |
| Reazur Rasul | PSU | 2025-03-06 | 26,220 | 52,440 | — | 104,880 | 2,024,184 |
| Joel Grade | RSU | 2025-03-06 | — | 1 | — | 29,538 | 1,046,827 |
| Joel Grade | RSU | 2025-09-02 | — | — | 102,712 | — | 2,482,549 |
| Joel Grade | OPTION | 2025-03-06 | — | — | 98,478 | — | 1,049,372 |
| Reazur Rasul | OPTION | 2025-03-06 | — | — | 87,417 | — | 931,507 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Joel Grade | $3,529,376 | $2,280,295 | $1,049,372 | 33.2% |
| Heather Knight | 1,264,287 | 2,753,994 | 1,267,349 | 52.1% |
| Brent Shafer | 2,400,815 | 0 | 0 | 0.0% |
| Andrew Hider | 8,895,768 | 14,237,750 | 3,185,053 | 54.1% |
| Reazur Rasul | 929,237 | 2,024,184 | 931,507 | 52.1% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Reazur Rasul | Option | 87,417 | 35.44 | — |
| David Rosenbloom | RSU | 17,884 | — | 341,760 |
| David Rosenbloom | RSU | 17,047 | — | 325,776 |
| Andrew Hider | RSU | 236,237 | — | 4,514,489 |
| Andrew Hider | RSU | 131,813 | — | 2,518,946 |
| Joel Grade | RSU | 102,712 | — | 1,962,826 |
| José Almeida | RSU | 93,183 | — | 1,780,735 |
| José Almeida | RSU | 83,343 | — | 1,592,683 |
| Andrew Hider | RSU | 82,170 | — | 1,570,259 |
| José Almeida | RSU | 74,363 | — | 1,421,068 |
| Reazur Rasul | RSU | 57,838 | — | 1,105,281 |
| Andrew Hider | RSU | 56,492 | — | 1,079,553 |
| Joel Grade | RSU | 22,309 | — | 426,317 |
| David Rosenbloom | RSU | 37,182 | — | 710,539 |
| Cecilia Soriano | RSU | 20,542 | — | 392,558 |
| Joel Grade | RSU | 30,489 | — | 582,652 |
| José Almeida | Option | 373,435 | 66.31 | — |
| Joel Grade | RSU | 29,915 | — | 571,674 |
| Joel Grade | RSU | 29,914 | — | 571,664 |
| Joel Grade | RSU | 29,745 | — | 568,423 |
| José Almeida | Option | 348,483 | 77.15 | — |
| Reazur Rasul | RSU | 26,555 | — | 507,458 |
| Joel Grade | RSU | 8,864 | — | 169,386 |
| José Almeida | RSU | 24,227 | — | 462,985 |
| Reazur Rasul | RSU | 18,942 | — | 361,989 |
| David Rosenbloom | RSU | 17,883 | — | 341,750 |
| Cecilia Soriano | RSU | 11,402 | — | 217,898 |
| José Almeida | Option | 534,759 | 50.77 | — |
| Joel Grade | RSU | 9,849 | — | 188,206 |
| José Almeida | Option | 381,437 | 75.75 | — |
| Cecilia Soriano | RSU | 7,226 | — | 138,090 |
| Reazur Rasul | RSU | 5,507 | — | 105,229 |
| David Rosenbloom | RSU | 4,956 | — | 94,713 |
| Cecilia Soriano | RSU | 2,644 | — | 50,518 |
| Heather Knight | Option | 20,000 | 75.84 | — |
| Cecilia Soriano | RSU | 2,273 | — | 43,441 |
| Andrew Hider | Option | 465,651 | 24.17 | — |
| José Almeida | Option | 342,933 | 74.73 | — |
| Heather Knight | Option | 59,700 | 39.06 | — |
| José Almeida | Option | 151,596 | 85.23 | — |
| José Almeida | Option | 93,815 | 39.06 | — |
| Heather Knight | Option | 24,807 | 85.23 | — |
| Joel Grade | Option | 34,091 | 36.55 | — |
| Reazur Rasul | Option | 8,334 | 51.21 | — |
| Joel Grade | Option | 98,478 | 35.44 | — |
| Heather Knight | Option | 18,861 | 74.73 | — |
| Heather Knight | Option | 20,979 | 75.75 | — |
| Heather Knight | Option | 21,780 | 77.15 | — |
| Alok Sonig | Option | 25,604 | 56.76 | — |
| Reazur Rasul | Option | 6,417 | 50.77 | — |
| David Rosenbloom | Option | 58,873 | 35.44 | — |
| Reazur Rasul | Option | 15,684 | 66.31 | — |
| Reazur Rasul | Option | 17,147 | 74.73 | — |
| Reazur Rasul | Option | 14,940 | 75.75 | — |
| Reazur Rasul | Option | 15,207 | 77.15 | — |
| Reazur Rasul | Option | 8,269 | 85.23 | — |
| Reazur Rasul | Option | 21,322 | 39.06 | — |
| David Rosenbloom | Option | 33,442 | 74.47 | — |
| David Rosenbloom | Option | 19,190 | 39.06 | — |
| Alok Sonig | Option | 42,643 | 39.06 | — |
| Cecilia Soriano | Option | 5,118 | 39.06 | — |
| Cecilia Soriano | Option | 23,787 | 35.44 | — |
We have designed our executive compensation program to attract, motivate, reward and retain the executive talent required to help achieve our corporate and strategic objectives and increase stockholder value.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon Consulting, Inc. (Aon) |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-05 | 401,367,909 | 38,914,808 | 584,694 | 91.16% | Passed |
| 2025 | 2025-05-06 | 405,175,420 | 40,433,760 | 580,601 | 90.93% | Passed |
| 2024 | 2024-05-07 | 375,646,141 | 57,650,282 | 827,605 | 86.53% | Passed |
| 2023 | 2023-05-02 | 308,247,917 | 88,194,108 | 1,067,883 | 77.75% | Passed |
| 2022 | 2022-05-03 | 375,423,883 | 37,478,137 | 902,278 | 90.92% | Passed |
| 2021 | 2021-05-04 | 372,124,431 | 35,259,771 | 1,342,941 | 91.34% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-05 | 91.16%a |
| 2025 | 2025-05-06 | 90.93%b |
| 2024 | 2024-05-07 | 86.53%c |
a. Approved under the standard stated in the filing — “Abstentions or directions to withhold authority will have no effect on the outcome of Proposal 1.”.
b. Approved under the standard stated in the filing — “Abstentions will have the same effect as a vote against any of the other matters specified in the Notice of Annual Meeting of Stockholders.”.
c. Approved under the standard stated in the filing — “Abstentions will have the same effect as a vote against any of the other matters specified in the Notice of Annual Meeting of Stockholders.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 445 : 1 |
|---|---|
| CEO total compensation | $32,199,341 |
| Median employee compensation | $72,402 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Nancy M. SchlichtingIndependent · Compensation and Human Capital (Chair) · Quality and Regulatory Compliance | $169,166 | $214,987 | — | — | $9,412 | $393,565 |
| Stephen N. OesterleIndependent | 140,000 | 214,987 | — | — | 19,500 | 374,487 |
| David S. WilkesIndependent · Nominating, Corporate Governance and Public Policy · Quality and Regulatory Compliance | 120,000 | 214,987 | — | — | 31,861 | 366,848 |
| Cathy R. SmithIndependent | 150,000 | 214,987 | — | — | 0 | 364,987 |
| Patricia B. MorrisonIndependent · Nominating, Corporate Governance and Public Policy (Chair) · Audit · Operating Committee | 120,000 | 214,987 | — | — | 26,598 | 361,585 |
| Jeffrey A. CraigIndependent · Audit (Chair) · Compensation and Human Capital | 145,000 | 214,987 | — | — | 0 | 359,987 |
| Amy A. WendellIndependent · Compensation and Human Capital · Quality and Regulatory Compliance · Operating Committee | 120,000 | 214,987 | — | — | 20,000 | 354,987 |
| Stephen H. RusckowskiIndependent · Operating Committee (Chair) | 120,000 | 214,987 | — | — | 20,000 | 354,987 |
| William A. Ampofo IIIndependent · Quality and Regulatory Compliance (Chair, effective May 2026) · Operating Committee | 120,000 | 214,987 | — | — | 2,449 | 337,436 |
| Brent ShaferEmployee director · Board Chair · Nominating, Corporate Governance and Public Policy · Not standing for re-election | 109,646 | 0 | — | — | 0 | 109,646 |
| Michael R. McDonnellIndependent · Audit · Not standing for re-election | — | — | — | — | — | — |
| Annual cash retainer | $120,000 |
|---|---|
| Annual equity retainer | $215,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 20,000 |
| Stock ownership guideline | $600,000 |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,313,812 |
| Equity awards (grant-date value) | $1,934,883 |
| All other compensation | $129,820 |
| Total cost of the board | $3,378,515 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies BAXTER INTERNATIONAL INC names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including BAXTER INTERNATIONAL INC.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | BAXTER INTERNATIONAL INC | 2025 | Andrew Hider | $499,315 | $23,133,518 | $3,185,053 | $820,125 | $29,805,182 |
| 2 | Abbott Laboratories | 2025 | Robert Ford | 1,500,000 | 8,787,378 | 8,788,430 | 1,968,750 | 24,198,660 |
| 3 | Danaher Corporation | 2025 | Rainer Blair | 1,400,000 | 9,292,370 | 8,386,657 | 4,194,400 | 23,795,280 |
| 4 | Boston Scientific Corporation | 2025 | Michael Mahoney | 1,442,603 | 13,608,056 | 3,749,980 | 4,002,001 | 23,532,050 |
| 5 | Medtronic Public Limited Company | 2026 | Geoffrey Martha | 1,399,039 | 13,672,200 | 5,175,559 | 2,307,200 | 22,940,252 |
| 6 | Stryker Corporation | 2025 | Kevin Lobo | 1,500,000 | 9,764,136 | 6,920,781 | 2,250,000 | 21,401,495 |
| 7 | Intuitive Surgical, Inc. | 2025 | David Rosa | 858,750 | 18,674,872 | 0 | 1,373,859 | 20,997,480 |
| 8 | GE HealthCare Technologies | 2025 | Peter Arduini | 1,324,983 | 11,249,533 | 3,624,970 | 2,081,084 | 18,562,794 |
| 9 | Laboratory Corporation of America Holdings | 2025 | Adam Schechter | 1,435,000 | 11,400,463 | 2,754,582 | 2,062,095 | 18,339,913 |
| 10 | DaVita Inc. | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 11 | Edwards Lifesciences | 2025 | Bernard Zovighian | 1,192,500 | 7,167,024 | 6,499,109 | 2,406,537 | 17,454,255 |
| 12 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 13 | Zimmer Biomet Holdings, Inc. | 2025 | Ivan Tornos | 1,281,846 | 12,000,101 | 0 | 2,420,767 | 16,106,550 |
| 14 | Hologic, Inc. | 2024 | Stephen MacMillan | 1,212,628 | 9,141,468 | 2,937,477 | 1,990,413 | 15,819,261 |
| 15 | Quest Diagnostics Incorporated | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 16 | Agilent Technologies, Inc. | 2025 | Padraig McDonnell | 1,141,345 | 8,169,850 | 2,017,759 | 1,436,809 | 12,827,236 |
| 17 | DENTSPLY Sirona Inc. | 2025 | Daniel Scavilla | 431,753 | 3,484,488 | 3,221,523 | 437,150 | 8,760,139 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| BAXTER INTERNATIONAL INC | not disclosed | not disclosed | No | Aon Consulting, Inc. (Aon) |
| Abbott Laboratories | 75.0% | Options 50 · PSU 50 | No | Meridian Compensation Partners, LLC |
| Agilent Technologies, Inc. | not disclosed | PSU 60 · Options 20 · RSU 20 | No | Semler Brossy |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Boston Scientific Corporation | 173% | PSU 50 · RSU 25 · Options 25 | No | Semler Brossy Consulting Group, LLC |
| Danaher Corporation | not disclosed | Options 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| DaVita Inc. | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| DENTSPLY Sirona Inc. | 66% | PSU 50 · Options 50 | No | Frederic W. Cook & Co., Inc. |
| Edwards Lifesciences | 127% | Options 50 · PSU 25 · RSU 25 | No | Semler Brossy Consulting Group |
| GE HealthCare Technologies | 101% | PSU 50 · Option 25 · RSU 25 | No | Semler Brossy |
| Hologic, Inc. | 109% | PSU 50 · RSU 25 · Option 25 | No | Pearl Meyer & Partners, LLC |
| Intuitive Surgical, Inc. | 115.2% | RSU 50 · PSU 50 | No | Aon |
| Laboratory Corporation of America Holdings | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
| Medtronic Public Limited Company | 103% | PSU 50 · Options 30 · RSU 20 | No | Semler Brossy |
| Quest Diagnostics Incorporated | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| Stryker Corporation | 100% | PSU 48 · Options 34 | No | Semler Brossy |
| Zimmer Biomet Holdings, Inc. | 125.9% | RSU 50 · PSU 50 | Yes — Relative TSR | Semler Brossy |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Andrew Hider | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 2 | Section 01, Joel Grade | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 8,209,568. Filing ↗machine: r13 · c30 · span 1469131–1469140 |
| 3 | Section 01, José Almeida | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 7,666,044. Filing ↗machine: r7 · c30 · span 1455811–1455820 |
| 4 | Section 01, Heather Knight | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 6,074,548. Filing ↗machine: r16 · c30 · span 1477697–1477706 |
| 5 | Section 01, Reazur Rasul | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 5,246,214. Filing ↗machine: r19 · c30 · span 1487086–1487095 |
| 6 | Section 01, Alok Sonig | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 5,239,273. Filing ↗machine: r25 · c30 · span 1496977–1496986 |
| 7 | Section 01, Brent Shafer | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 3,809,993. Filing ↗machine: r10 · c30 · span 1464395–1464404 |
| 8 | Section 01, David Rosenbloom | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 3,794,164. Filing ↗machine: r22 · c30 · span 1492259–1492268 |
| 9 | Section 01, Cecilia Soriano | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Summary Compensation Table” · page 65. As printed: 2,654,841. Filing ↗machine: r28 · c30 · span 1505572–1505581 |
| 10 | Section 03, Joel Grade PSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t188 · r4 · c4 · span 1309022–1309028 |
| 11 | Section 03, Heather Knight OPTION | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r16 · c9 · span 1476461–1476470 |
| 12 | Section 03, Heather Knight PSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t188 · r5 · c4 · span 1310863–1310869 |
| 13 | Section 03, Brent Shafer RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r10 · c7 · span 1462760–1462769 |
| 14 | Section 03, Heather Knight RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t188 · r5 · c5 · span 1311124–1311130 |
| 15 | Section 03, Andrew Hider RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r4 · c1 · span 883352–883353 |
| 16 | Section 03, Andrew Hider RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t137 · r4 · c1 · span 883352–883353 |
| 17 | Section 03, Andrew Hider OPTION | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r4 · c9 · span 1449791–1449800 |
| 18 | Section 03, Andrew Hider PSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 19 | Section 03, Andrew Hider PSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 20 | Section 03, Reazur Rasul RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t188 · r6 · c5 · span 1312816–1312822 |
| 21 | Section 03, Andrew Hider PSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 22 | Section 03, Reazur Rasul PSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t188 · r6 · c4 · span 1312555–1312561 |
| 23 | Section 03, Joel Grade RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r13 · c5 · span 1468390–1468391 |
| 24 | Section 03, Joel Grade RSU | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t222 · r34 · c7 · span 1770495–1770502 |
| 25 | Section 03, Joel Grade OPTION | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r13 · c6 · span 1468390–1468399 |
| 26 | Section 03, Reazur Rasul OPTION | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r19 · c6 · span 1486347–1486354 |
| 27 | Section 07, pay ratio | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “CEO Pay Ratio”. As printed: 445 : 1. Filing ↗ |
| 28 | Section 08, Nancy M. Schlichting | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 393,565. Filing ↗machine: span 826281–826402 |
| 29 | Section 08, Stephen N. Oesterle | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 374,487. Filing ↗machine: span 822875–822996 |
| 30 | Section 08, David S. Wilkes | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 366,848. Filing ↗machine: span 833347–833468 |
| 31 | Section 08, Cathy R. Smith | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 364,987. Filing ↗machine: span 829968–830225 |
| 32 | Section 08, Patricia B. Morrison | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 361,585. Filing ↗machine: span 821354–821475 |
| 33 | Section 08, Jeffrey A. Craig | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 359,987. Filing ↗machine: span 819696–819953 |
| 34 | Section 08, Amy A. Wendell | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 354,987. Filing ↗machine: span 831620–831741 |
| 35 | Section 08, Stephen H. Rusckowski | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 354,987. Filing ↗machine: span 824579–824700 |
| 36 | Section 08, William A. Ampofo II | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 337,436. Filing ↗machine: span 818202–818323 |
| 37 | Section 08, Brent Shafer | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: 109,646. Filing ↗machine: span 827191–827312 |
| 38 | Section 08, Michael R. McDonnell | DEF 14A | 2026-03-23 | 0001628280-26-020330 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 39 | Section 02, Jeffrey A. Craig 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032135 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Michael R. McDonnell 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032141 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Brent Shafer 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032168 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Patricia B. Morrison 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032176 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Nancy M. Schlichting 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032184 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, David S. Wilkes 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032196 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Amy A. Wendell 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032190 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, William A. Ampofo II 2026-05-05 | Form 4 | 2026-05-07 | 0001628280-26-032127 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Anita A. Zielinski 2026-06-01 | Form 4 | 2026-06-03 | 0001628280-26-040231 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, James Teaff 2026-06-02 | Form 4 | 2026-06-03 | 0001628280-26-040214 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Steven P. Wallace 2026-06-02 | Form 4 | 2026-06-03 | 0001628280-26-040222 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, James Teaff 2026-09-01 | Form 4 | 2026-09-03 | 0001628280-26-060479 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Julie Foster 2026-09-02 | Form 4 | 2026-09-03 | 0001628280-26-060469 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Andrew Hider 2026-09-02 | Form 4 | 2026-09-03 | 0001628280-26-060476 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 06, 2026 vote | Form 8-K | 2026-05-08 | 0001193125-26-214680 | Item 5.07 · say-on-pay result. As reported: 91.16% (votes for as printed: 401,367,909). Filing ↗ |
| 54 | Section 06, 2025 vote | Form 8-K | 2025-05-08 | 0001628280-25-023809 | Item 5.07 · say-on-pay result. As reported: 90.93% (votes for as printed: 405,175,420). Filing ↗ |
| 55 | Section 06, 2024 vote | Form 8-K | 2024-05-09 | 0001628280-24-022267 | Item 5.07 · say-on-pay result. As reported: 86.53% (votes for as printed: 375,646,141). Filing ↗ |
| 56 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 57 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 58 | Section 09b board cost (computed) | Computed | — | — | Cash 1,313,812 + equity 1,934,883 + all other 129,820 = 3,378,515, summed across the director compensation table rows.machine: formula: Σ = 3,378,515 |
| 59 | BAXTER INTERNATIONAL INC (subject), Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020330 | CEO total compensation as printed in BAXTER INTERNATIONAL INC's own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 60 | Abbott Laboratories, Section 10b CEO total | DEF 14A | 2026-03-13 | 0001308179-26-000064 | CEO total compensation as printed in Abbott Laboratories's own proxy. As printed: 24,198,660. Filing ↗machine: span 1245488–1245498 |
| 61 | Danaher Corporation, Section 10b CEO total | DEF 14A | 2026-03-25 | 0000313616-26-000101 | CEO total compensation as printed in Danaher Corporation's own proxy. As printed: 23,795,280. Filing ↗machine: t122 · r2 · c21 · span 1070180–1070190 |
| 62 | Boston Scientific Corporation, Section 10b CEO total | DEF 14A | 2026-03-18 | 0000885725-26-000025 | CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. Filing ↗machine: r2 · c27 · span 1249807–1249817 |
| 63 | Medtronic Public Limited Company, Section 10b CEO total | DEF 14A | 2026-08-17 | 0001613103-26-000010 | CEO total compensation as printed in Medtronic Public Limited Company's own proxy. As printed: 22,940,252. Filing ↗machine: span 988220–988230 |
| 64 | Stryker Corporation, Section 10b CEO total | DEF 14A | 2026-03-23 | 0000310764-26-000013 | CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989 |
| 65 | Intuitive Surgical, Inc., Section 10b CEO total | DEF 14A | 2026-03-13 | 0001035267-26-000023 | CEO total compensation as printed in Intuitive Surgical, Inc.'s own proxy. As printed: 20,997,480. Filing ↗machine: r2 · c48 · span 762289–762299 |
| 66 | GE HealthCare Technologies, Section 10b CEO total | DEF 14A | 2026-03-19 | 0001932393-26-000021 | CEO total compensation as printed in GE HealthCare Technologies's own proxy. As printed: 18,562,794. Filing ↗machine: r3 · c39 · span 924977–924987 |
| 67 | Laboratory Corporation of America Holdings, Section 10b CEO total | DEF 14A | 2026-04-10 | 0001193125-26-150752 | CEO total compensation as printed in Laboratory Corporation of America Holdings's own proxy. As printed: 18,339,913. Filing ↗machine: t153 · r3 · c22 · span 3147696–3147706 |
| 68 | DaVita Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0000927066-26-000053 | CEO total compensation as printed in DaVita Inc.'s own proxy. As printed: 18,210,597. Filing ↗machine: r2 · c45 · span 800715–800725 |
| 69 | Edwards Lifesciences, Section 10b CEO total | DEF 14A | 2026-03-26 | 0001099800-26-000015 | CEO total compensation as printed in Edwards Lifesciences's own proxy. As printed: 17,454,255. Filing ↗machine: r2 · c27 · span 965441–965451 |
| 70 | Becton, Dickinson and Company, Section 10b CEO total | DEF 14A | 2025-12-18 | 0001628280-25-057846 | CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295 |
| 71 | Zimmer Biomet Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-01 | 0001193125-26-135661 | CEO total compensation as printed in Zimmer Biomet Holdings, Inc.'s own proxy. As printed: 16,106,550. Filing ↗machine: t111 · r3 · c16 · span 1895785–1895795 |
| 72 | Hologic, Inc., Section 10b CEO total | DEF 14A | 2025-01-16 | 0001140361-25-001287 | CEO total compensation as printed in Hologic, Inc.'s own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674 |
| 73 | Quest Diagnostics Incorporated, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013356 | CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337 |
| 74 | Agilent Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-02-06 | 0001193125-26-040286 | CEO total compensation as printed in Agilent Technologies, Inc.'s own proxy. As printed: 12,827,236. Filing ↗machine: r3 · c29 · span 1450982–1450992 |
| 75 | DENTSPLY Sirona Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0000818479-26-000125 | CEO total compensation as printed in DENTSPLY Sirona Inc.'s own proxy. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387 |
| 76 | Section 10a, Danaher Corporation reciprocity | DEF 14A | — | 0000313616-26-000101 | Danaher Corporation's most recent proxy was read; its disclosed peer group does not include BAXTER INTERNATIONAL INC. Filing ↗ |
| 77 | Section 10a, Stryker Corporation reciprocity | DEF 14A | — | 0000310764-26-000013 | Stryker Corporation names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 78 | Section 10a, Becton, Dickinson and Company reciprocity | DEF 14A | — | 0001628280-25-057846 | Becton, Dickinson and Company names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 79 | Section 10a, Zimmer Biomet Holdings, Inc. reciprocity | DEF 14A | — | 0001193125-26-135661 | Zimmer Biomet Holdings, Inc. names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 80 | Section 10a, Agilent Technologies, Inc. reciprocity | DEF 14A | — | 0001193125-26-040286 | Agilent Technologies, Inc. names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 81 | Section 10a, Quest Diagnostics Incorporated reciprocity | DEF 14A | — | 0001140361-26-013356 | Quest Diagnostics Incorporated names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 82 | Section 10a, DENTSPLY Sirona Inc. reciprocity | DEF 14A | — | 0000818479-26-000125 | DENTSPLY Sirona Inc.'s most recent proxy was read; its disclosed peer group does not include BAXTER INTERNATIONAL INC. Filing ↗ |
| 83 | Section 10a, Edwards Lifesciences reciprocity | DEF 14A | — | 0001099800-26-000015 | Edwards Lifesciences names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 84 | Section 10a, GE HealthCare Technologies reciprocity | DEF 14A | — | 0001932393-26-000021 | GE HealthCare Technologies names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 85 | Section 10a, Boston Scientific Corporation reciprocity | DEF 14A | — | 0000885725-26-000025 | Boston Scientific Corporation names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 86 | Section 10a, Hologic, Inc. reciprocity | DEF 14A | — | 0001140361-25-001287 | Hologic, Inc. names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 87 | Section 10a, Intuitive Surgical, Inc. reciprocity | DEF 14A | — | 0001035267-26-000023 | Intuitive Surgical, Inc.'s most recent proxy was read; its disclosed peer group does not include BAXTER INTERNATIONAL INC. Filing ↗ |
| 88 | Section 10a, DaVita Inc. reciprocity | DEF 14A | — | 0000927066-26-000053 | DaVita Inc. names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 89 | Section 10a, Laboratory Corporation of America Holdings reciprocity | DEF 14A | — | 0001193125-26-150752 | Laboratory Corporation of America Holdings names BAXTER INTERNATIONAL INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the BAXTER INTERNATIONAL INC Executive Compensation Report
$1,500